![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Mitrychem S.a.s. Mitry-mory Fr, based in France, is a pharmaceutical company.
One of their significant offerings is Etodolac, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2013-084 - Rev 01
This Chemical Type CEP, issued on February 13, 2015, remains in force until June 20, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 1422 associated with this CEP further emphasizes